Recent Articles from MarketBeat

MarketBeat is an American financial media company headquartered in Sioux Falls, South Dakota, founded in 2011 by Matthew Paulson as Analyst Ratings Network before rebranding in 2015. The company operates an online platform that delivers real-time financial data, market analysis, and news, aiming to empower individual investors with tools to make informed trading decisions.

Insmed Sees BRINSUPRI Reaching $7 Billion in Peak Sales, Expects Cash-Flow Positive Year Aheadmarketbeat.com
Insmed (NASDAQ:INSM) expects its bronchiectasis drug BRINSUPRI to generate $1.35 billion to $1.4 billion in its first full year of launch, Chief Executive Officer Will Lewis said, as the company looks to reach more patients and expand its pipeline. Speaking at the Jefferies Global Healthcare Confer
Via MarketBeat · November 17, 2026
Solid Biosciences Eyes FDA Fast-Track Path for Duchenne Gene Therapy, Potential 2027 Filingmarketbeat.com
Solid Biosciences (NASDAQ:SLDB) plans to meet with the U.S. Food and Drug Administration before the end of 2026 to discuss a potential accelerated approval pathway for its Duchenne muscular dystrophy gene therapy, CEO Bo Cumbo said at a Jefferies fireside chat. The company has dosed 53 patients wit
Via MarketBeat · November 17, 2026
Rollins Tests AI Marketing as Digital Leads Drop and Growth Target Faces Uncertaintymarketbeat.com
Rollins (NYSE:ROL) is testing new marketing approaches as consumers increasingly use artificial intelligence platforms to find pest-control providers, Chief Financial Officer Will Harkins said at a discussion hosted by RBC analyst Ashish Sabadra. Harkins said the company has brought in multiple mar
Via MarketBeat · November 17, 2026
United Therapeutics Prepares for TYVASO Expansion After $833 Million Quartermarketbeat.com
United Therapeutics (NASDAQ:UTHR) is preparing for a potential expansion of its TYVASO franchise into idiopathic pulmonary fibrosis, while its executives pointed to strong third-quarter sales and a pipeline of regulatory and clinical milestones at the UBS London Healthcare Conference. The company r
Via MarketBeat · November 16, 2026
Agora Q3 Earnings Call Highlightsmarketbeat.com
Agora (NASDAQ:API) reported third-quarter 2026 revenue of $42.1 million, up 19% from a year earlier, as growth in its real-time engagement business and increasing contributions from conversational artificial intelligence products helped drive a third consecutive quarter of accelerating revenue growt
Via MarketBeat · November 16, 2026
Yalla Group Q3 Earnings Call Highlightsmarketbeat.com
Yalla Group (NYSE:YALA) reported a modest increase in third-quarter revenue as new games began contributing to sales, but higher marketing and development expenses weighed on earnings. Management said it expects the gaming business to drive double-digit revenue growth in 2027 while warning that prof
Via MarketBeat · November 16, 2026
Standard Lithium Q3 Earnings Call Highlightsmarketbeat.com
Standard Lithium (NYSEAMERICAN:SLI) expects to make a final investment decision on its South West Arkansas lithium project by the end of the first quarter of 2027, a timeline that means the company expects to forgo a $40 million payment from joint venture partner Equinor. CEO David Park said the co
Via MarketBeat · November 16, 2026
Intermap Technologies Q3 Earnings Call Highlightsmarketbeat.com
Intermap Technologies (TSE:IMP) reported higher third-quarter revenue but a wider loss as delays in an Indonesian mapping procurement and costs associated with its acquisition of PCI Geomatics weighed on results. Revenue rose 5% to $1.8 million, while the net loss widened to $4 million, or $0.05 pe
Via MarketBeat · November 16, 2026
VEON Targets Up to $9 Billion in Revenue by 2030 as Fintech and AI Drive Growthmarketbeat.com
VEON (NASDAQ:VEON) outlined plans to grow revenue by 12% to 15% annually in U.S. dollar terms through 2030, as it expands financial services, entertainment and artificial intelligence offerings on top of its telecommunications networks. At the company’s Capital Markets Day, Chief Executive Officer
Via MarketBeat · November 16, 2026
K92 Mining Q3 Earnings Call Highlightsmarketbeat.com
K92 Mining (TSE:KNT) reported its second-highest quarterly production on record in the third quarter of 2026, but posted a net loss after recording a $90.3 million non-cash deferred tax charge tied to earnings retained in Papua New Guinea. The company produced 49,776 gold equivalent ounces, up abou
Via MarketBeat · November 16, 2026
What PagSeguro Digital (PAGS) Said on Its Q3 Earnings Callmarketbeat.com
PagSeguro Digital (NYSE:PAGS) cut its 2026 gross profit growth forecast after slower-than-expected interest rate reductions in Brazil, even as third-quarter earnings rose on growth in credit and banking and lower funding costs. The company, which operates as PagBank, now expects gross profit to inc
Via MarketBeat · November 16, 2026
Aquestive Therapeutics Eyes Needle-Free Allergy Treatment Launch Ahead of 2027 FDA Decisionmarketbeat.com
Aquestive Therapeutics (NASDAQ:AQST) is preparing for a potential U.S. launch of its needle-free treatment for severe allergic reactions, with an FDA decision expected on March 16, 2027, CEO Dan Barber said at the 2026 Jefferies Global Healthcare Conference. The company’s lead product candidate, An
Via MarketBeat · November 16, 2026
PICS Q3 Earnings Call Highlightsmarketbeat.com
PicPay, operated by PICS (NASDAQ:PICS), reported rapid credit growth and higher third-quarter earnings, while outlining an upcoming change to its loan write-off policy that it expects to reduce fourth-quarter net income by approximately BRL 325 million. The company’s credit portfolio reached BRL 35
Via MarketBeat · November 16, 2026
What Infleqtion (INFQ) Said on Its Q3 Earnings Callmarketbeat.com
Infleqtion (NYSE:INFQ) reported third-quarter revenue growth and maintained its full-year sales guidance, while executives pointed to a quantum computing milestone and rising customer commitments as signs of momentum heading into 2027. Revenue rose 25% from a year earlier to $9.1 million, though it
Via MarketBeat · November 16, 2026
XP Q3 Earnings Call Highlightsmarketbeat.com
XP (NASDAQ:XP) reported higher third-quarter revenue and adjusted earnings as growth in its retail and corporate businesses helped offset a challenging environment for capital markets. The company also announced a new share buyback and dividend, while executives outlined expectations for revenue gro
Via MarketBeat · November 16, 2026
What H&R Real Estate Investment Trust (HR.UN) Said on Its Q3 Earnings Callmarketbeat.com
H&R Real Estate Investment Trust (TSE:HR.UN) reported a decline in third-quarter funds from operations and a drop in net asset value after recording substantial property valuation adjustments, while management said its future strategy would be reviewed by a refreshed board following the failure
Via MarketBeat · November 16, 2026
Omeros Q3 Earnings Call Highlightsmarketbeat.com
Omeros (NASDAQ:OMER) reported higher third-quarter sales of its transplant complication treatment YARTEMLEA and a second consecutive quarter of positive operating cash flow, while a non-cash adjustment tied to its convertible notes pushed the company to a net loss. YARTEMLEA generated $35.9 million
Via MarketBeat · November 16, 2026
What Red Cat (RCAT) Said on Its Q3 Earnings Callmarketbeat.com
Red Cat (NASDAQ:RCAT) withdrew its full-year 2026 revenue target after anticipated funding and contract awards failed to materialize on the expected timeline and its FANG drone was not selected as a finalist in the Drone Dominance II competition. The autonomous systems company reported third-quarte
Via MarketBeat · November 16, 2026
What SharonAI (SHAZ) Said on Its Q3 Earnings Callmarketbeat.com
SharonAI (NASDAQ:SHAZ) expects its annualized revenue run rate to rise to $400 million to $450 million in January 2027, up from approximately $50 million in September, as it brings artificial intelligence computing capacity online for customers. On its third-quarter earnings call, the Australian AI
Via MarketBeat · November 16, 2026
PTC Therapeutics Sees $2 Billion-Plus Sephience Potential, Sets January Guidance Datemarketbeat.com
PTC Therapeutics (NASDAQ:PTCT) expects to provide 2027 sales guidance for its oral phenylketonuria treatment Sephience in January, as executives seek to convince investors that the drug’s strong first year of sales can be sustained. Speaking at the Jefferies Healthcare Conference in London, CEO Mat
Via MarketBeat · November 16, 2026
What Live Oak Acquisition Corp. V (TMS) Said on Its Q3 Earnings Callmarketbeat.com
Teamshares said it expects a surge in acquisitions to drive a sharp increase in earnings by the end of 2026, after completing six deals since the third quarter closed and securing nonbinding agreements for additional businesses. On its third-quarter earnings call, management said revenue rose 24% f
Via MarketBeat · November 16, 2026
Precision Optics Q1 Earnings Call Highlightsmarketbeat.com
Precision Optics (NASDAQ:POCI) reported a 22% increase in fiscal first-quarter revenue and a narrower loss, but executives said a slowdown in satellite component shipments will make the current quarter the weakest of the year. Revenue for the quarter ended September 30, 2026, rose to $8.2 million f
Via MarketBeat · November 16, 2026
Soluna Q3 Earnings Call Highlightsmarketbeat.com
Soluna (NASDAQ:SLNH) reported a wider third-quarter loss as wind farm repairs and higher expenses offset revenue growth, while management said its priority is converting prospective tenants at two artificial intelligence data center campuses into signed leases. Revenue rose 80% from a year earlier
Via MarketBeat · November 16, 2026
What Oncocyte (IMDX) Said on Its Q3 Earnings Callmarketbeat.com
Insight Molecular Diagnostics (IMDX) expects to respond before a January 2027 deadline to the U.S. Food and Drug Administration’s request for more information about its GraftAssureDx kidney transplant test, executives said on the company’s third-quarter earnings call. President and CEO Josh Riggs s
Via MarketBeat · November 16, 2026
Capstone Energy+ Q2 Earnings Call Highlightsmarketbeat.com
Capstone Energy+ (NASDAQ:CEPL) said its fiscal second-quarter results fell short of expectations as lower rental fleet utilization, weaker product revenue and elevated service costs weighed on performance. The company also announced a refinancing of a debt note due in December. President and CEO Vi
Via MarketBeat · November 16, 2026
Skillz Q3 Earnings Call Highlightsmarketbeat.com
FIRY Inc., which operates Skillz (NYSE:FIRY), reported third-quarter revenue growth of 14% as its RZR advertising business more than doubled sales from a year earlier, offsetting a decline in Skillz revenue. Revenue rose to $31 million from the year-earlier quarter and increased 1% sequentially. Th
Via MarketBeat · November 16, 2026
ReposiTrak Q1 Earnings Call Highlightsmarketbeat.com
ReposiTrak (NYSE:TRAK) reported lower revenue and profit for its fiscal first quarter of 2027, while executives said an expanded investment in SPAR Group and early results from a joint retail service could support future growth. Revenue was $5.8 million, down approximately 3% from a year earlier bu
Via MarketBeat · November 16, 2026
FitLife Brands Q3 Earnings Call Highlightsmarketbeat.com
FitLife Brands (NASDAQ:FTLF) reported third-quarter revenue of $25.6 million, up 9% from a year earlier, as a full quarter of revenue from Irwin more than offset a decline in its Legacy FitLife business. Net income rose 71% to $1.6 million, or $0.16 per diluted share, from $0.9 million, or $0.09 pe
Via MarketBeat · November 16, 2026
Wrap Technologies Q3 Earnings Call Highlightsmarketbeat.com
Wrap Technologies (NASDAQ:WRAP) reported flat third-quarter revenue and a wider net loss as it shifted its sales strategy toward multiyear programs combining its restraint technology with training and ongoing customer support. Revenue was $1.5 million, unchanged from a year earlier. Executive Chair
Via MarketBeat · November 16, 2026
What Duos Technologies Group (DUOT) Said on Its Q3 Earnings Callmarketbeat.com
Duos Technologies Group (NASDAQ:DUOT) reported third-quarter 2026 revenue of $10.5 million, more than double its year-earlier total, as its technology solutions business grew and the company completed a shift toward operating colocation compute centers. Management said it expects fourth-quarter rev
Via MarketBeat · November 16, 2026
AbCellera Biologics Targets 2027 Late-Stage Trial for Hot Flash Treatmentmarketbeat.com
AbCellera Biologics (NASDAQ:ABCL) is preparing to advance its experimental hot flash treatment ABCL635 into late-stage studies, with a registrational trial potentially starting around the middle of 2027, Chief Executive Carl Hansen said at the Jefferies 2026 Global Healthcare Conference in London.
Via MarketBeat · November 16, 2026
Contango ORE Q3 Earnings Call Highlightsmarketbeat.com
Contango ORE (NYSEAMERICAN:CTGO) executives said the company has no plans to raise $75 million through an equity financing, seeking to clarify an at-the-market share program while addressing higher mining costs and a quarterly loss. CEO Rick Van Nieuwenhuyse said the company’s shelf registration an
Via MarketBeat · November 16, 2026
Venu Q3 Earnings Call Highlightsmarketbeat.com
Venu (NYSEAMERICAN:VENU) reported higher revenue for the first nine months of fiscal 2026 as restaurant sales grew, while management outlined plans to finance and open new entertainment venues and increase bookings at its Colorado Springs amphitheater. Revenue for the nine months ended September 30
Via MarketBeat · November 16, 2026
Verastem Weighs Partnership or Solo Launch as Cancer Drug Trials Advancemarketbeat.com
Verastem (NASDAQ:VSTM) is preparing a broad development program for its experimental cancer drug VS-7375, with incoming CEO Michael Bailey saying the company is considering both partnerships and a potential independent launch as it awaits midstage trial results. At an investor discussion hosted by
Via MarketBeat · November 16, 2026
Chemtrade Logistics Income Fund Q3 Earnings Call Highlightsmarketbeat.com
Chemtrade Logistics Income Fund (TSE:CHE.UN) expects adjusted EBITDA to rise in 2027, with lower sulphur costs potentially benefiting its water treatment business and no major turnaround scheduled at its North Vancouver chlor-alkali plant, executives said during the company’s third-quarter earnings
Via MarketBeat · November 16, 2026
Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?marketbeat.com
Via MarketBeat · November 16, 2026
Orbiting Growth: Federal Contracts Boost Viasat's Outlookmarketbeat.com
Via MarketBeat · November 16, 2026
Ionis Pharmaceuticals Sticks to $3 Billion TRYNGOLZA Sales Goal Despite Slow Startmarketbeat.com
Ionis Pharmaceuticals (NASDAQ:IONS) remains confident that its triglyceride-lowering drug TRYNGOLZA can generate more than $3 billion in peak annual U.S. sales, even as its launch has started more slowly than expected, CEO Brett Monia said at the UBS Global Biopharma Conference. Monia said physicia
Via MarketBeat · November 16, 2026
Lucara Diamond Q3 Earnings Call Highlightsmarketbeat.com
Lucara Diamond (TSE:LUC) raised its 2026 revenue guidance after reporting third-quarter sales of $61.5 million, including the sale of a 1,300-carat diamond recovered in July. President and CEO William Lamb said the company now expects annual revenue of $140 million to $160 million, up from its prev
Via MarketBeat · November 16, 2026
APN Resources H2 Earnings Call Highlightsmarketbeat.com
Applied Nutrition reported a 50.9% rise in fiscal 2026 revenue and forecast further growth in fiscal 2027, as the sports nutrition company invests in U.K. production capacity and expands its manufacturing presence in the United States. Revenue rose to £161.6 million, while adjusted earnings before
Via MarketBeat · November 16, 2026
What XPENG (XPEV) Said on Its Q3 Earnings Callmarketbeat.com
XPENG (NYSE:XPEV) reported higher third-quarter revenue and a narrower sequential loss as vehicle deliveries and average selling prices rose, while management projected record deliveries and revenue for the final quarter of 2026. The electric vehicle maker also outlined plans to more than double ov
Via MarketBeat · November 16, 2026
Ballard Power Systems Q3 Earnings Call Highlightsmarketbeat.com
Ballard Power Systems (NASDAQ:BLDP) reported a 31% decline in third-quarter revenue as fuel cell customer deliveries shifted into later years, while improved margins and lower operating costs narrowed its adjusted EBITDA loss. The results included approximately one month of operations from GeoPura,
Via MarketBeat · November 16, 2026
What Aramark (ARMK) Said on Its Q4 Earnings Callmarketbeat.com
Aramark (NYSE:ARMK) reported $20.1 billion in fiscal 2026 revenue and projected another year of strong growth, as new client wins, high retention and its expanding Nexus business helped drive results. The food and facilities services company said organic revenue rose 10% for the year. It forecast o
Via MarketBeat · November 16, 2026
Pearl Diver Credit Q3 Earnings Call Highlightsmarketbeat.com
Pearl Diver Credit (NYSE:PDCC) reported a decline in net asset value in the third quarter of 2026 as unrealized investment losses outweighed net investment income. Management said cash flows from its collateralized loan obligation portfolio continued to exceed distributions and expenses, even as inv
Via MarketBeat · November 16, 2026
What Tyson Foods (TSN) Said on Its Q4 Earnings Callmarketbeat.com
Tyson Foods (NYSE:TSN) expects sales to decline in fiscal 2027 as tight cattle supplies and a restructured beef network reduce volume, even as the company projects a substantial improvement in its beef business. The meat processor forecast adjusted operating income of $1.7 billion to $2.15 billion
Via MarketBeat · November 16, 2026
What TOYO (TOYO) Said on Its Q3 Earnings Callmarketbeat.com
TOYO (NASDAQ:TOYO) reported lower third-quarter revenue and profit as trade proceedings disrupted shipments from its Ethiopian solar cell facility, while its expanding Texas module business helped drive growth in third-party sales. Total revenue fell 4.8% from a year earlier to $129.0 million, Chie
Via MarketBeat · November 16, 2026
Modine Manufacturing Scales Up to Solve the AI Heat Problemmarketbeat.com
Via MarketBeat · November 16, 2026
Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questionsmarketbeat.com
Via MarketBeat · November 16, 2026
What KE (BEKE) Said on Its Q3 Earnings Callmarketbeat.com
KE (NYSE:BEKE) reported higher third-quarter 2026 transaction value and operating profit despite a decline in revenue, as cost reductions and improved margins across its businesses helped offset weaker reported revenue from rentals and home renovation. Gross transaction value rose 4.5% from a year
Via MarketBeat · November 16, 2026
What Blackstone Digital Infrastructure Trust (BXDC) Said on Its Q3 Earnings Callmarketbeat.com
Blackstone Digital Infrastructure Trust (NYSE:BXDC) has agreed to acquire a 75% interest in a $5 billion portfolio of data centers through a sale-leaseback with Amazon, marking the company’s first investment since its initial public offering. The transaction covers 13 newly constructed powered-shel
Via MarketBeat · November 16, 2026
AirJoule Technologies Q3 Earnings Call Highlightsmarketbeat.com
AirJoule Technologies (NASDAQ:AIRJ) expects its newly acquired BitSink business to generate $15 million to $20 million in revenue in 2027, supported by $15 million in signed purchase orders for modular data center infrastructure, executives said on the company’s third-quarter earnings call. The out
Via MarketBeat · November 16, 2026
Cypherpunk Technologies Q3 Earnings Call Highlightsmarketbeat.com
Cypherpunk Technologies (NASDAQ:CYPH) reported its first quarterly operating profit in the third quarter of 2026, as the launch of its Zcash mining business generated $9.9 million in revenue during a partial quarter of operations. The company posted $2.6 million in income from operations and $306 m
Via MarketBeat · November 16, 2026
What Outdoor (POWW) Said on Its Q2 Earnings Callmarketbeat.com
Outdoor (NASDAQ:POWW) reported higher revenue and earnings for its fiscal second quarter as transaction volume grew on its GunBroker marketplace and a newer firearms transfer service added fees. Management also said marketplace activity increased after the midterm elections, although it did not char
Via MarketBeat · November 16, 2026
Lexeo Therapeutics Q3 Earnings Call Highlightsmarketbeat.com
Lexeo Therapeutics (NASDAQ:LXEO) reported interim data from a small, early-stage trial of its gene therapy LX2020, saying patients who received the higher dose showed reductions in abnormal heart rhythms and improvements in other measures of PKP2-associated arrhythmogenic cardiomyopathy. The compan
Via MarketBeat · November 16, 2026
Embraer's Record Backlog Looks Promising, But Can It Keep Its Margins Climbing?marketbeat.com
Via MarketBeat · November 16, 2026
3 AI Hardware Leaders Are Raising Dividends, But Which Offers More Income?dividendstocks.com
TSMC, Seagate, and Western Digital all raised dividends recently amid strong AI-driven sales and earnings growth, with analysts seeing further stock upside ahead.
Via MarketBeat · November 16, 2026
Could Big Buybacks Be the Next Catalyst for These 3 AI Stocks?marketbeat.com
Via MarketBeat · November 16, 2026
Iovance Biotherapeutics Targets 2027 Lung Cancer Filing as AMTAGVI Sales Climbmarketbeat.com
Iovance Biotherapeutics (NASDAQ:IOVA) is preparing to seek a lung cancer indication for its cell therapy AMTAGVI in 2027 while expanding its melanoma treatment network and advancing studies in earlier-stage melanoma and rare sarcomas, executives said at a Jefferies event. The company reported appro
Via MarketBeat · November 16, 2026
Baidu Q3 Earnings Call Highlightsmarketbeat.com
Baidu (NASDAQ:BIDU) said its general business returned to year-over-year revenue growth in the third quarter of 2026 as demand for AI computing helped offset pressure on its advertising business. General business revenue rose 1% to CNY 25.0 billion, while total company revenue fell 1% to CNY 30.8 b
Via MarketBeat · November 16, 2026
Niu Technologies Q3 Earnings Call Highlightsmarketbeat.com
Niu Technologies (NASDAQ:NIU) reported a third-quarter net loss as revenue growth lagged a rise in vehicle sales, with overseas inventory clearance and weaker demand for premium electric bicycles in China weighing on results. The electric two-wheeler maker sold 537,457 units in the third quarter of
Via MarketBeat · November 16, 2026
iQIYI Q3 Earnings Call Highlightsmarketbeat.com
iQIYI (NASDAQ:IQ) returned to a non-GAAP operating profit in the third quarter of 2026 as content costs fell, even as total revenue declined from the preceding quarter. The video platform reported revenue of CNY 6 billion, down 4% sequentially, and non-GAAP operating income of CNY 25 million, compa
Via MarketBeat · November 16, 2026
Montauk Renewables Q3 Earnings Call Highlightsmarketbeat.com
Montauk Renewables (NASDAQ:MNTK) reported higher third-quarter revenue but lower profit and said it is seeking a credit facility amendment and potential shareholder financing as operational challenges delay higher production at its Turkey, North Carolina, project. Revenue rose 10.9% to $50.2 millio
Via MarketBeat · November 16, 2026
Sandisk's Sell-Off May Be Losing Steam, But the Biggest Risk Still Loomsmarketbeat.com
Via MarketBeat · November 16, 2026
Axsome Therapeutics Sees AUVELITY Prescription Surge After Alzheimer’s Agitation Launchmarketbeat.com
Axsome Therapeutics (NASDAQ:AXSM) executives said growth in new prescriptions for AUVELITY and an expanded sales team are positioning the company for further growth following the drug’s launch for Alzheimer’s disease agitation. Speaking at the UBS Biopharma Conference in London, Chief Financial Off
Via MarketBeat · November 16, 2026
What H World Group (HTHT) Said on Its Q3 Earnings Callmarketbeat.com
H World Group (NASDAQ:HTHT) raised its full-year revenue growth guidance after reporting higher third-quarter revenue and profit, as expansion of its managed and franchised hotel network helped offset a decline in revenue from leased and owned properties. The hotel operator said group revenue rose
Via MarketBeat · November 16, 2026
Meta's Access to Capital Remains Strong, But Borrowing Is Becoming More Expensivemarketbeat.com
Via MarketBeat · November 16, 2026
3 Large-Cap Stocks Are Outperforming the S&P 500 Without AI Hypemarketbeat.com
Via MarketBeat · November 16, 2026
BioMarin Pharmaceutical Sees $2.6 Billion Sales Potential in Amicus Drugs as VOXZOGO Expansion Loomsmarketbeat.com
BioMarin Pharmaceutical (NASDAQ:BMRN) expects growth from its acquired rare disease treatments, an expanded market for VOXZOGO and a pipeline that could deliver patient data in 2027, Chief Executive Officer Alexander Hardy said at the UBS Global Biopharma Conference. Hardy said the company’s global
Via MarketBeat · November 16, 2026
Fossil Just Turned a Profit—Can Its Comeback Survive the Holidays?marketbeat.com
Via MarketBeat · November 16, 2026
Beaming Up the Backlog: AeroVironment Lands $405M Laser Dealmarketbeat.com
Via MarketBeat · November 16, 2026
Vertex Pharmaceuticals Prepares for Key Kidney Drug Decision as Pipeline Readouts Loommarketbeat.com
Vertex Pharmaceuticals (NASDAQ:VRTX) is preparing for a Nov. 30 U.S. regulatory decision on its kidney disease treatment povetacicept, while awaiting clinical results across kidney disease, chronic pain and other conditions, company executives said at a UBS investor event. Susie Lisa, Vertex’s seni
Via MarketBeat · November 16, 2026
What Sirius Real Estate (SRE) Said on Its H1 Earnings Callmarketbeat.com
Sirius Real Estate (LON:SRE) reported a 12% rise in funds from operations for the six months ended September 30, as acquisitions and higher rents helped offset rising financing costs. The owner and operator of business parks in Germany and the U.K. said funds from operations, or FFO, rose to EUR 72
Via MarketBeat · November 16, 2026
WESCO International’s Data Center Sales Surge 300% to $6 Billion, With No Slowdown in Sightmarketbeat.com
WESCO International (NYSE:WCC) said its data center sales have grown more than 300% since early 2024, reaching approximately $6 billion on a trailing 12-month basis as the company expands beyond connectivity equipment into power infrastructure and services. Data centers now account for more than 20
Via MarketBeat · November 16, 2026
Ninety One Group H1 Earnings Call Highlightsmarketbeat.com
Ninety One Group (LON:N91) reported higher assets, revenue and adjusted earnings for the half year ended Sept. 30, 2026, but unexpected client outflows and underperformance in some equity strategies tempered the asset manager’s results. Assets under management rose 19% to £181.4 billion, despite ne
Via MarketBeat · November 16, 2026
BILL Bets on Bigger Customers and AI After Deep Job Cuts, Sees Growth Reboundmarketbeat.com
BILL (NYSE:BILL) is shifting its focus toward revenue growth after a restructuring that reduced headcount by roughly 35% to 40% over the past year, Chief Financial Officer Rohini Jain said at a Citi financial technology event. Jain said the company’s priorities now include attracting larger custome
Via MarketBeat · November 16, 2026
Articles from MarketBeat | FWNBC